15-deoxy-Δ12,14-Prostaglandin J2-d9

15-deoxy-Δ12,14-Prostaglandin J2-d9 （订货以CAS编码或英文名称为准）

Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Endocrinology & Metabolism|Hormones & Receptors|PPARs||Research Area|Endocrinology & Metabolism|Metabolic Diseases||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PC55357

CAS号：937370-10-0

储存条件：-20

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PC55357-10mg	Medlife	10mg	≥95%	待询	登录后可见
PC55357-25mg	Medlife	25mg	≥95%	待询	登录后可见
PC55357-50mg	Medlife	50mg	≥95%	待询	登录后可见
PC55357-100mg	Medlife	100mg	≥95%	待询	登录后可见
PC55357-100µg	Medlife	EA		¥4811.00	登录后可见

中文名称：	培美曲塞杂质E
中文别名：	培美曲塞杂质E;培美曲塞杂质E Disodium Salt;培美曲塞二钠杂质E;培美曲赛杂质2;培美曲塞二钠EP杂质E;(R)-培美曲塞;培美曲塞杂质E (EP/BP);培美曲塞EP杂质E二钠盐;培美曲塞杂质05;培美曲赛杂质E
英文名称：	15-deoxy-Δ12,14-Prostaglandin J2-d9
英文别名：	Pemetrexed Impurity E;P219490;PeMetrexed IMpurity E;Pemetrexed EP Impurity E Disodium Salt;D-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-, disodium salt;Pemetrexed EP Impurity E 2Na;Pemetrexed impurity 5/Pemetrexed EP Impurity E Disodium Salt/(2R)-2-[[4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid, sodium (1:2);Pemetrexed Impurity E Disodium Salt;sodium (4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d] pyrimidin-5-yl)ethyl)benzoyl)-D-glutamate
CAS号：	937370-10-0
详细描述	Application\|Mass Spectrometry\|\|Product Type\|Biochemicals\|Analytical Standards\|\|Product Type\|Biochemicals\|Isotopically Labeled Standards\|Deuterium\|\|Product Type\|Biochemicals\|Lipids\|Prostaglandins\|\|Research Area\|Endocrinology & Metabolism\|Hormones & Receptors\|PPARs\|\|Research Area\|Endocrinology & Metabolism\|Metabolic Diseases\|\|Research Area\|Lipid Biochemistry\|Cyclooxygenase Pathway

搜索质检报告(COA)

相关产品

sodium ((S)-4-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d] pyrimidin-5-yl)ethyl)benzamido)-4-carboxylatobutanoyl)-L-glutamate

(2S)-dimethyl 2-(4-(4-oxobutan-2-yl)benzamido)pentanedioate

sodium (4-(2-(2-amino-1-methyl-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d] pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate

(2S,2'S)-2,2'-((4,4'-((2,2'-diamino-4,4',6-trioxo-1,4,4',6,7,7'-hexahydro-1'H,5H-[5,6'-bipyrrolo[2,3-d]pyrimidine]-5,5'-diyl)bis(ethane-2,1-diyl))bis(benzoyl))bis(azanediyl))diglutaric acid

sodium (4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d] pyrimidin-5-yl)ethyl)benzoyl)-D-glutamate

(S)-dimethyl 2-(4-(4-oxobutyl)benzamido)pentanedioate

(4-(2-(2-amino-4,6-dioxo-4,5,6,7-tetrahydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-L-glutamic acid

Monoacetylphloroglucinol (hydrate)

15-deoxy-Δ12,14-Prostaglandin J2-d9

HDAC8 (human, recombinant)